Navigation Links
Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria
Date:5/20/2013

MOUNTAIN VIEW, Calif., May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the publication of results of the first study demonstrating detection of pathogenic bacteria, including potential bioterrorism agents such as Yersinia pestis and Bacillus anthracis which feature on the Center for Disease Control and Prevention's list of potential bio-threats. This seminal study, conducted in collaboration with the Defence Science and Technology Laboratory, Salisbury (DSTL), United Kingdom, researchers reported 100% bacterial identification accuracy at inoculum concentrations as low as 8 colony-forming units.  The study also demonstrated a simple method to differentiate strains of the same species, including 5 strains of Yersinia pestis and Bacillus anthracis.

(Photo: http://photos.prnewswire.com/prnh/20130520/CG16830)

Current standard practice for identification of pathogenic bacteria requires completion of a culture and then requires additional time consuming molecular or chemical analysis. Specific Technologies has developed a system for identifying microorganisms from their metabolic signature during culture saving precious hours during potentially deadly incidents.

In the event of a suspected release, a rapid and reliable method to identify potential bioterrorism agents would allow a faster public health response. Current bacterial identification methods can be slow and require highly trained personnel to operate sophisticated instruments that are generally too expensive, delicate, or bulky to deploy outside of a dedicated laboratory facility.

Ray Martino a founder and COO of Specific Technologies, commented, "Microorganisms produce a complex mixture of volatile metabolites unique to their species and strain.  Specific Technologies has developed a system for identifying the species and strain from their metabolic signature during culture, saving the delay and cost of molecular or chemical methods that follow culture"

Mr. Martino continued, "The Specific Technologies sensor is small and disposable. The instrumentation is no more than what is found in common smart phones enabling the use of the solution in the field."

The publication in PLOS ONE http://dx.plos.org/10.1371/journal.pone.0062726 is now available.

About Specific Technologies

Specific Technologies has developed in vitro diagnostic systems for rapid identification of microorganisms to diagnose infections that lead to serious medical conditions including sepsis. The company's unique, patented, metabolomic signature technology identifies microorganisms during culture growth before existing technologies based on molecular or chemical tests can be deployed resulting in faster diagnosis with less labor and no additional instruments. Specific Technologies is located in Mountain View, CA.

For additional information on the Company, please visit www.specifictechnologies.net

Media Contact: Anders Berliner , Specific Technologies, 561-659-5400, aberliner@specifictechnologies.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Specific Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
2. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
3. MD Bioproducts releases HLA-B27 subtype specific antibody.
4. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
6. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
7. BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September
8. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
9. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
10. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
11. Sequenom CMMs MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)...  Forté Elements, LLC (Forté) is excited to announce the launch of its Mediceutical ... needs of recovery for a variety of clinical conditions. Founded in 2013, Forté spent ... http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)... 2016 Kalorama Information noted the 5 Most ... in a recent white paper.  The healthcare market research ... a growing market are among the top drivers of ... EMR 2016: The Market for Electronic Medical ... study of the EMR industry, and the report is ...
(Date:5/2/2016)... , May 2, 2016  While nearly three-quarters ... osteoporosis can have on their health, only about half ... according to the results of a new survey announced ... mark the start of National Osteoporosis Month, Hologic is ... which affects nearly 56 million Americans. Osteoporosis ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... ... Hight-Doland Insurance Agency’s new community involvement program which serves families of the ... Southwest Louisiana to help provide positive mentoring for local youth. Donations to this worthy ... Southwest Louisiana has been helping to guide the area’s youth for over 30 years, ...
(Date:5/4/2016)... Dallas, Texas (PRWEB) , ... May 04, 2016 , ... ... cancer awareness in people across the United States. Dermatologist Dr. Ellen Turner is encouraging ... heed dermatology experts’ advice and focus on skin safety and health now and in ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... is transforming breastfeeding for nursing mothers. The company’s patented technology, The Smart Breastfeeding ... Today, the company announced that the technology is now available for purchase at ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Francesca Loparco, Co-Founder ... her life forever with a same-day LASIK procedure at Christenbury Eye Center. ... Dr. Jonathan Christenbury performed her surgery the same day as her in-office consultation and ...
(Date:5/4/2016)... Beverly Hills, CA (PRWEB) , ... May 04, 2016 , ... ... comprehensive care that ex-supermodel Janice Dickinson needed following breast cancer surgery. In March 2016, ... in situ, a type of breast cancer that occurs in the milk ducts, according ...
Breaking Medicine News(10 mins):